Pharmaceutical Company Purchases Failed DNA Collection Firm, Gaining Entry To World’s Largest Genetic Database
Regeneron to Acquire 23andMe for $256 Million Regeneron Pharmaceuticals, a U.S. biotechnology firm, has announced its acquisition of genetic testing company 23andMe following a winning bid of $256 million during a bankruptcy auction. This move comes as part of a broader strategy to enhance access to genetic data. The acquisition allows Regeneron to obtain a […]
Trump’s Drug Price Strategy and the Pharmaceutical Trade Conflict
Trump’s Drug Price Orders Challenge Foreign Free-Riding For many years, American consumers have faced some of the highest drug prices globally. The government has opted not to engage in negotiations. In contrast, other nations have instituted strict price caps and demanded significant discounts from pharmaceutical companies, while the US has permitted drug manufacturers to set […]
From Qatar to QVAR, Trump Challenges Boeing and Major Pharmaceutical Companies
Trump’s Executive Order on Drug Prices Faces Criticism Over Foreign Interests In a move that garnered significant praise, President Donald Trump announced an executive order on Monday aimed at lowering prescription drug prices in the U.S. The initiative encourages drug manufacturers to voluntarily reduce prices, with the federal health department compensating them for the lowered […]
Democrats Who Praised Biden’s Pharmaceutical Moves Completely Change Their Stance on Trump’s Drug Pricing Order
Democratic lawmakers who previously supported former President Joe Biden’s initiatives against the pharmaceutical industry are now commending President Trump’s recent executive order. On Monday, Trump issued a significant executive order aimed at reducing prescription drug prices, claiming reductions might reach up to 90%. In a recent post, Trump stated, “If you think the price of […]
Cigna and CVS stocks drop as Trump aims at ‘middlemen’ in broad executive order against major pharmaceutical companies.
Trump Targets Prescription Drug Prices with New Executive Order President Trump made headlines on Monday by signing an executive order aimed at slashing prescription drug prices for Americans by up to 90%. This move had an immediate impact, particularly on shares of companies he dubbed as “intermediate.” At the White House ceremony, Trump stated, “We’ve […]
The abortion pill issue that the pharmaceutical industry wants to hide
A recent study has revealed that women face serious adverse effects from chemical abortions at a rate that is 22 times higher than what the FDA and manufacturers disclose. This calls for federal intervention, as leaving the responsibility to states is insufficient for safeguarding women. If these drugs pose such risks, major pharmaceutical companies should […]
FDA appoints a critic of COVID policies and the pharmaceutical industry to head the vaccines division
The Food and Drug Administration has appointed Vinay Prasad, known for his critical stance on federal Covid-19 policies and a proponent of more rigorous approval processes, to head its vaccine division. He takes over from Peter Marks, who had been with the Center for Biological Assessment and Research until his resignation in March, reportedly due […]
The issue of plastic prescription bottles in the pharmaceutical industry receives a paper alternative.
Have you ever thought about what happens to all those little orange pill bottles after you’ve filled your prescription? Each year, approximately 200 billion of these bottles are produced globally, with a significant portion ending up in landfills. In the United States alone, about 4 to 5 billion plastic pill bottles are discarded yearly. That’s […]
Trump’s pharmaceutical tariffs will risk the lives of American patients
On April 1st, the Trump administration investigationWhether importing drugs poses national security risks. Considering a relatively short periodPublic CommentsThe answer seems to be a natural conclusion. Customs duties are expectedMid May. These obligations are not just a waste of financially. It slams the US healthcare system. Furthermore, unlike the “mutual” tariffs announced on April 2nd, Commerce […]
US begins inquiry into pharmaceutical and chip imports in bid to impose tariffs | Trump administration
The Trump administration has launched an investigation into drug and semiconductor imports as part of its bid to impose tariffs on both sectors for national security reasons, a notice posted Monday showed. The submission, scheduled to be published on Wednesday, marks the 21-day deadline from that date for submission of public comments on the issue, […]